2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide, also known as TMN 355, is a potent and selective chemical inhibitor of cyclophilin A (CypA), a protein involved in inflammation and atherosclerosis. It acts by reducing foam cell formation and the secretion of inflammatory cytokines.